Independent. Trusted. Proven.
Expert buy, hold and sell recommendations from our team of analysts.
Here are three more stocks I’d be delighted to find as my Christmas present this year. You might feel the same way!
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk at Morgans, notes that Morgans research team maintains a BUY rating on Sonic Healthcare (SHL).
For the week ending Friday 5 December 2025, FNArena registered eight upgrades in broker ratings for individual ASX-listed stocks and 10 downgrades.
The year is winding down, but markets aren't. This week we put some of the market’s biggest names under the microscope.
Is this Thanksgiving week stocks comeback the real thing or a real turkey?
This week, Peter Switzer is rejoined by co-host Paul Rickard. Together, the pair take on the higher than expected inflation result, why the market dislikes tech and growth stocks right now, and a few old favourites.
Here are the reasons I think higher inflation is here to stay – and how investors can respond by focusing on assets suited to those conditions.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains why he sees South32 (S32) offering an opportunity at its current levels.
If the Aussie dollar continues to rise, are there any ETFs I can access to reduce the financial impact on my US shares? Why do the index weights of the major industry sectors change from month to month? Do the major brokers see price upside for Sonic Health Care? Why have term deposit rates gone up, with Macquarie paying 4.25% for 12 months?
This is a crucial question for all investors because if I predict a sell-off and I’m right, then being defensive, say in cash, will get you around 4% while those exposed to growth could lose 15% or more.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.